Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of opioids on P2Y12 receptor inhibition in STEMI patients pre-treated with crushed ticagrelor
2017-002671-26Phase 4Active
- Sponsor
- Isala
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ticagrelor in myocardial infarction (MI) (2 arms), sponsored by Isala. Started Jul 2017; status: active.
02
Drugs
ticagrelor
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2017-002671-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002671-26.